FRIDAY, Dec. 21, 2018 -- Two common classes of type 2 diabetes drugs may lower blood sugar levels, but new research suggests those same drugs might boost the risk of heart attack, stroke and heart failure.
The drug classes in question are sulfonylureas and basal insulin. Sulfonylureas cause the body to release more insulin. They're taken orally and have been used since the 1950s. Basal insulin is given as an injection, and it's engineered to be released slowly throughout the day.
WEDNESDAY, Dec. 26, 2018 -- The bacteria living in your digestive system might determine how your body processes diabetes medications, a new review suggests.
Researchers combed through more than 100 published studies conducted in people or in rodents to see how the gut microbiome -- bacteria living in the digestive system -- could impair or enhance the way diabetes drugs work.
THURSDAY, Jan. 3, 2019 -- If you have type 2 diabetes and you're taking canagliflozin to help control your blood sugar, a new study has some good news for you: The drug doesn't appear to raise the risk of bone fractures.
Previously, research had suggested this might be the case.
MONDAY, Nov. 26, 2018 -- There are many areas of the United States where doctors are in short supply, but the good news for diabetics is that nurse practitioners and physician assistants can often help fill that care gap.
In fact, new research compared the care given by doctors, nurse practitioners and physician assistants to people with diabetes and found no significant differences in care.